Abstract
Autoimmune diseases (ADs) are now the fastest growing disease category for autologous hematopoietic cell transplantation (aHCT). Despite the evolution of competing biological and targeted therapies...
Funding Information
  • funded

This publication has 27 references indexed in Scilit: